About Progen: Progen Pharmaceuticals is a globally focused biotechnology company on the discovery, development and commercialization of small molecule drugs primarily for the treatment of cancer. Progen has operations in Australia and the U.S get full text . This press release contains forward-looking statements based on management’s current expectations. These statements can be assigned significantly from actual future events or results due to certain risks and uncertainties, including, without limitation, risks associated with the drug development and manufacture, risks extensive approval process by the United States Food and Drug Administration and the Australian Therapeutic Goods Administration, delays in obtaining the necessary approvals for clinical testing, patient recruitment, delays in the conduct of clinical trials, market acceptance of PI-88, PI-166 and other drugs, future capital needs, general economic conditions and other risks and uncertainties from time to time. In the company’s filings with the Australian Securities Exchange and the United States Securities and Exchange Commission Furthermore, there is no guarantee that others can not develop similar products or processes independently or design around patents owned or licensed by the Company be, or that patents owned or licensed by the Company meaningful protection or competitive advantages.
Early over 3000 types of about 170 different species of plant are published through the direct intervention the IAEA: them include barley that ft to 5000 meters and tear which saline soils saline soil and grows these varieties offer much-needed food as well as millions of dollars in economic benefits farmers and consumers, particularly in the developing countries.